2021 欧洲专家共识:恶性血液病患者继发性抗体缺乏的治疗

2021-01-16 国外血液科相关专家小组 Eur J Haematol . 2021 Jan 16.

继发性抗体缺乏(SAD)与严重,反复或持续性感染有关,常见于恶性血液病患。但对这类患者的免疫球蛋白替代治疗(IgRT)缺乏统一指导,本文主要针对恶性血液病患者继发性抗体缺乏应用IgRT治疗的相关内容提

中文标题:

2021 欧洲专家共识:恶性血液病患者继发性抗体缺乏的治疗

英文标题:

Treating Secondary Antibody Deficiency in Patients with Haematological Malignancy: European Expert Consensus

发布日期:

2021-01-16

简要介绍:

继发性抗体缺乏(SAD)与严重,反复或持续性感染有关,常见于恶性血液病患。但对这类患者的免疫球蛋白替代治疗(IgRT)缺乏统一指导,本文主要针对恶性血液病患者继发性抗体缺乏应用IgRT治疗的相关内容提供共识指导。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 欧洲专家共识:恶性血液病患者继发性抗体缺乏的治疗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=235491c0020a220c, title=2021 欧洲专家共识:恶性血液病患者继发性抗体缺乏的治疗, enTitle=Treating Secondary Antibody Deficiency in Patients with Haematological Malignancy: European Expert Consensus, guiderFrom=Eur J Haematol . 2021 Jan 16., authorId=0, author=, summary=继发性抗体缺乏(SAD)与严重,反复或持续性感染有关,常见于恶性血液病患。但对这类患者的免疫球蛋白替代治疗(IgRT)缺乏统一指导,本文主要针对恶性血液病患者继发性抗体缺乏应用IgRT治疗的相关内容提, cover=https://img.medsci.cn/2021124/1611503528356_2020535.jpg, journalId=0, articlesId=null, associationId=971, associationName=国外血液科相关专家小组, associationIntro=null, copyright=0, guiderPublishedTime=Sat Jan 16 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>继发性抗体缺乏(SAD)与严重,反复或持续性感染有关,常见于恶性血液病患。但对这类患者的免疫球蛋白替代治疗(IgRT)缺乏统一指导,本文主要针对恶性血液病患者继发性抗体缺乏应用IgRT治疗的相关内容提供共识指导。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=43020, tagName=恶性血液病)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=43020, guiderKeyword=恶性血液病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7763, appHits=63, showAppHits=0, pcHits=329, showPcHits=7700, likes=2, shares=6, comments=2, approvalStatus=1, publishedTime=Mon Jan 25 00:35:07 CST 2021, publishedTimeString=2021-01-16, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sun Jan 24 23:52:14 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 13:56:17 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 欧洲专家共识:恶性血液病患者继发性抗体缺乏的治疗.pdf)])
2021 欧洲专家共识:恶性血液病患者继发性抗体缺乏的治疗.pdf
下载请点击:
评论区 (0)
#插入话题

拓展阅读

恶性血液病患者药物性肝损伤的预防和规范化治疗中国专家共识(2021年版)

中国临床肿瘤学会(CSCO,Chinese Society of Clinical Oncology) · 2021-03-30

2022 DGHO建议:恶性血液病患者侵袭性真菌疾病的一级预防

德国血液学和肿瘤学学会(DGHO,German Society of Hematology and Oncology) · 2023-06-13